Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection
about
Inhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisAlveolar inflammation in cystic fibrosis.Inhaled corticosteroids for cystic fibrosis.Clinical implications of inflammation in young children.The role of inhaled corticosteroids in the management of cystic fibrosis.Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosisCystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.Anti-inflammatory therapies for cystic fibrosis-related lung disease.Targeting airway inflammation in cystic fibrosis in children: past, present, and future.Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasoneItraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Serial lung function and responsiveness in cystic fibrosis during early childhood.Inhaled corticosteroids for cystic fibrosisPerceived benefits of inhaled therapies in cystic fibrosis
P2860
Q24193120-50EEC310-AF68-4E36-BFCF-D55D50D78B6EQ24202923-8AF64D5B-9865-48A3-A858-C4943E3D38D0Q24241634-7689879E-F13C-4431-9B50-51A1CE0943C5Q33905883-F259F19E-5A54-42D1-B635-7B6891CE73D6Q33910014-C75109E4-5E87-43E4-BA88-54796AC5E775Q33996589-2808467D-5333-435C-8A62-085B54B2C2E5Q34131911-D0B92A69-9D99-44EE-B32B-C79AFDEE3AAEQ36114460-88B8AB5C-A799-45C7-8183-CA1BD1DE39D7Q36412679-8A370C37-BC80-474D-AE75-10AF6D584547Q36924692-28FD953C-8BA6-4BA7-9C12-71DEFC0BE584Q37188760-3AF1B746-6DAA-48EC-B1B9-F1E58713F200Q37866284-F2CCEBC9-AB13-4E9D-B08F-421B4504EBEFQ38094297-35B320F5-784E-422F-B2A8-B6C992DB9FF3Q39507297-4466465D-1AD3-420B-BC6C-BDCF67859922Q44066338-61214EAF-0856-43B2-B73B-394147EF9258Q48005271-132B2C90-A70B-430B-A3E9-47548EE615C9Q56084189-4D5E72EF-E2AC-418B-A7E4-EF9FFAFB51F7Q57913759-B829DC74-96D5-4832-9D30-0CCD1B36173C
P2860
Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection
description
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1997
@uk
name
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@en
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@nl
type
label
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@en
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@nl
prefLabel
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@en
Controlled Trial of Inhaled Bu ...... seudomonas aeruginosaInfection
@nl
P2093
P2860
P1476
Controlled trial of inhaled bu ...... uedomonas aeruginosa infection
@en
P2093
Kronborg G
Laursen EM
Pedersen SS
Reimert CM
P2860
P304
P356
10.1164/AJRCCM.156.4.9612044
P407
P433
P577
1997-10-01T00:00:00Z